Literature DB >> 17274491

Changes in the biochemical profiles of mid-cervically located adenosine A1 receptors after repeated theophylline administration in adult rats.

Rubabe S Saharan1, Kwaku D Nantwi.   

Abstract

BACKGROUND/
OBJECTIVE: Adenosine A1 receptors localized in the phrenic motoneurons (PMNs), where the axons of the descending bulbospinal respiratory make synaptic contacts, may be involved in theophylline-induced respiratory-related activity in rats. The objective of this study was to characterize the biochemical profiles of adenosine A1 receptors in 2 groups of rats: (a) naïve and (b) theophylline-treated (3-day oral administration).
METHODS: Biochemical binding characteristics of adenosine A1 receptors in the C3 to C5 (PMN) of adult rats were assessed in naïve (n = 6) and theophylline-treated animals (n = 6) using [3H]-DPCPX (10 pmol/L to 30 nmol/L), the specific adenosine A1 receptor antagonist in saturation-binding assays. Competition assays used theophylline as the competing ligand (20 mmol/L to 20 pmol/L), and protein concentration was determined with the Bradford assay using a range of standards (0.016-1.0 mg/mL).
RESULTS: In saturation-binding assays in naïve animals, the A1 receptor was characterized by a single binding site with Bmax and Kd values of 256.00 +/- 32.13 fmol/mg protein and 2.89 +/- 0.45 nmol/L, respectively. Analysis of the isotherm in theophylline-treated animals showed 1 site with Bmax and Kd values of 219.00 +/- 26.3 fmol/mg protein and 0.60 +/- 0.21 nmol/L, respectively, and a second site characterized by Bmax and Kd values of 492.6 +/- 3.15 fmol/mg protein and 14.09 +/- 2.06 nmol/L, respectively.
CONCLUSIONS: Theophylline administration revealed 2 binding sites on receptors (characterized by the specific adenosine A1 antagonist, [3H]-DPCPX) located in the vicinity of phrenic motoneurons (C3-C5). Alteration of the receptor profiles after theophylline may underlie the respiratory-related actions of the drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17274491      PMCID: PMC1949029          DOI: 10.1080/10790268.2006.11753902

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  36 in total

Review 1.  Adenosine receptor subtypes: characterization and therapeutic regulation.

Authors:  M E Olah; G L Stiles
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

Review 2.  Receptors for purines and pyrimidines.

Authors:  V Ralevic; G Burnstock
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

3.  Actions of systemic theophylline on hemidiaphragmatic recovery in rats following cervical spinal cord hemisection.

Authors:  K D Nantwi; A El-Bohy; H G Goshgarian
Journal:  Exp Neurol       Date:  1996-07       Impact factor: 5.330

4.  Fetal cardiovascular and breathing responses to an adenosine A2a receptor agonist in sheep.

Authors:  B J Koos; A Chau
Journal:  Am J Physiol       Date:  1998-01

5.  A novel kainate receptor ligand [3H]-(2S,4R)-4-methylglutamate: pharmacological characterization in rabbit brain membranes.

Authors:  N J Toms; M E Reid; W Phillips; M C Kemp; P J Roberts
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

6.  Role of adenosine receptors in caffeine tolerance.

Authors:  S G Holtzman; S Mante; K P Minneman
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

7.  Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number.

Authors:  V Georgiev; B Johansson; B B Fredholm
Journal:  Brain Res       Date:  1993-05-28       Impact factor: 3.252

8.  The effect of centrally administered adenosine on fetal breathing movements.

Authors:  J M Bissonnette; A R Hohimer; S J Knopp
Journal:  Respir Physiol       Date:  1991-05

9.  Effects of neonatal exposure to caffeine on adenosine A1 receptor ontogeny using autoradiography.

Authors:  B A Etzel; R Guillet
Journal:  Brain Res Dev Brain Res       Date:  1994-10-14

10.  Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.

Authors:  G B Kaplan; D J Greenblatt; M A Kent; M M Cotreau-Bibbo
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.